Genelabs Technologies, Inc. (NASDAQ:GNLB)
1.29
-0 (-0%)
| Genelabs Technologies, Inc. (NASDAQ:GNLB) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.29 | 52 Week High | $1.30 | ||
| Open | $1.29 | 52 Week Low | $0.21 | ||
| Day High | $1.29 | P/E | N/A | ||
| Day Low | $1.29 | EPS | $-0.26 | ||
| Volume | 34,792 | ||||
| More GNLB Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GSK | 5 | EMAG | 1 |
| HSSO | 1 | WSTF | 1 |
| DSCP | 1 | SAY | 1 |
Entities who have mentioned GNLB
- Susquehanna International Group of Companies | View Related Stories »
- UBS | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Credit Suisse | View Related Stories »
- Goldman Sachs | View Related Stories »
- Citi | View Related Stories »
- Lazard | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
View All ReportsStreetInsider.com Reports on GNLB
- Notable Mergers and Acquisitions of the Day 1/7: SAY, DSCP, GSK/GNLB
- GlaxoSmithKline (GSK) Completes Tender Offer for Shares of Genelabs (GNLB)
- Notable Mergers and Acquisitions of the Day 12/30: HSSO/EMAG, WSTF, GSK/GNLB
- GlaxoSmithKline (GSK) Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies (GNLB)
- GlaxoSmithKline (GSK) Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies
StreetInsider Reports on GNLB by Category
View All BlogsBlogs on GNLB
- Achillion Pharma: Hepatitis Drug Dev Pipeline Now Fully Funded
- GlaxoSmithKline to Acquire Genelabs Technologies For $57M
Comments on GNLB
No comments are currently available.
